Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.3%

14 terminated/withdrawn out of 599 trials

Success Rate

88.6%

+2.1% vs industry average

Late-Stage Pipeline

11%

68 trials in Phase 3/4

Results Transparency

2%

2 of 109 completed trials have results

Key Signals

30 recruiting2 with results7 terminated7 withdrawn

Enrollment Performance

Analytics

N/A
266(64.1%)
Phase 2
55(13.3%)
Phase 3
35(8.4%)
Phase 4
33(8.0%)
Phase 1
21(5.1%)
Early Phase 1
5(1.2%)
415Total
N/A(266)
Phase 2(55)
Phase 3(35)
Phase 4(33)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (599)

Showing 20 of 599 trials
NCT02083835Recruiting

PAIN OUT: Improvement in Postoperative PAIN OUTcome

Role: collaborator

NCT07361224Phase 1Recruiting

Investigator Initiated Study to Assess the Safety of Combination of CLS-015 With Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive Large B Cell Lymphoma at Lymphodepletion.

Role: lead

NCT04673266Phase 2Completed

Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma

Role: collaborator

NCT05908708Recruiting

Closed-loop Medtronic 780G System in Youth With Type 1 Diabetes

Role: collaborator

NCT07104136Not ApplicableEnrolling By Invitation

Improving Adherence to COPD Treatments in Primary Care

Role: lead

NCT05489380Not ApplicableCompleted

Optical Diagnosis Versus Laser Measurement of Polyps' Size During Colonoscopy and Implications for Surveillance

Role: collaborator

NCT07380737Not ApplicableRecruiting

Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot Study

Role: lead

NCT05837884Recruiting

Predicting Progression of Developing Myeloma in a High-Risk Screened Population and General Population

Role: lead

NCT07327021Phase 2Recruiting

MRI-Guided Neoadjuvant Treatment De-Escalation in Stage II-III TNBC

Role: lead

NCT03080948Completed

Risk Stratification Among Individuals Who Have Many Moles on Their Skin

Role: collaborator

NCT06201728Not ApplicableEnrolling By Invitation

The Effect of Asthma Flare-up Clinic After Exacerbation

Role: lead

NCT07235332Enrolling By Invitation

Assessing Toxic Metal Exposure From Vegetarian/Vegan, Omnivorous, and Low-carb Diets in Israel.

Role: lead

NCT05592938Not ApplicableRecruiting

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Role: collaborator

NCT06723795Not ApplicableRecruiting

Cardiovascular Assessment and Treatment During COPD Exacerbation to Improve Diagnosis and Outcomes

Role: lead

NCT07191249Phase 2Not Yet Recruiting

A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma (LTB-FL).

Role: lead

NCT03560375Phase 4Completed

Mediterranean Diet, Circuit Resistance Training, Empagliflozin in Elderly With Type 2 Diabetes: a Study Protocol

Role: lead

NCT07145281Not ApplicableCompleted

Comparing the Effects of Sublingual Estradiol Treatment Versus Oral Estradiol With Cyproterone Acetate (CPA) Treatment on The Coagulation System in Transgender Women: A Prospective, Controlled Cohort Study

Role: lead

NCT07131163Recruiting

Real World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Resection

Role: collaborator

NCT07105787Not ApplicableRecruiting

Steps Against the Burden of Parkinson's Disease - TelAviv/Bologna

Role: collaborator

NCT06944119Active Not Recruiting

Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia

Role: lead